alpha-synuclein and Glaucoma--Open-Angle

alpha-synuclein has been researched along with Glaucoma--Open-Angle* in 1 studies

Other Studies

1 other study(ies) available for alpha-synuclein and Glaucoma--Open-Angle

ArticleYear
α-Synuclein modulates fibronectin expression in the trabecular meshwork independent of TGFβ2.
    Experimental eye research, 2023, Volume: 226

    α-Synuclein (α-Syn) is implicated in Parkinson's disease (PD), a neuromotor disorder with prominent visual symptoms. The underlying cause of motor dysfunction has been studied extensively, and is attributed to the death of dopaminergic neurons mediated in part by intracellular aggregation of α-Syn. The cause of visual symptoms, however, is less clear. Neuroretinal degeneration due to the presence of aggregated α-Syn has been reported, but the evidence is controversial. Other symptoms including those arising from primary open angle glaucoma (POAG) are believed to be the side-effects of medications prescribed for PD. Here, we explored the alternative hypothesis that dysfunction of α-Syn in the anterior eye alters the interaction between the actin cytoskeleton of trabecular meshwork (TM) cells with the extracellular matrix (ECM), impairing their ability to respond to physiological changes in intraocular pressure (IOP). A similar dysfunction in neurons is responsible for impaired neuritogenesis, a characteristic feature of PD. Using cadaveric human and bovine TM tissue and primary human TM cells as models, we report two main observations: 1) α-Syn is expressed in human and bovine TM cells, and significant amounts of monomeric and oligomeric α-Syn are present in the AH, and 2) primary human TM cells and human and bovine TM tissue endocytose extracellular recombinant monomeric and oligomeric α-Syn via the prion protein (PrP

    Topics: alpha-Synuclein; Animals; Cattle; Cells, Cultured; Fibronectins; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Trabecular Meshwork; Transforming Growth Factor beta2

2023